161 related articles for article (PubMed ID: 34954786)
1. Radionuclide imaging of hypoxia: Where are we now? Special attention to cancer of the cervix uteri.
Mokoala KMG; Lawal IO; Jeong JM; Sathekge MM; Vorster M
Hell J Nucl Med; 2021; 24(3):247-261. PubMed ID: 34954786
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. An overview of the developments and potential applications of
Bresser PL; Vorster M; Sathekge MM
Ann Nucl Med; 2021 Feb; 35(2):148-158. PubMed ID: 33400147
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro and in vivo characterization of two novel 68Ga-labelled 5-nitroimidazole derivatives as potential agents for imaging hypoxia.
Fernández S; Dematteis S; Giglio J; Cerecetto H; Rey A
Nucl Med Biol; 2013 Feb; 40(2):273-9. PubMed ID: 23218939
[TBL] [Abstract][Full Text] [Related]
5. 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals.
Fani M; André JP; Maecke HR
Contrast Media Mol Imaging; 2008; 3(2):67-77. PubMed ID: 18383558
[TBL] [Abstract][Full Text] [Related]
6. Insight into Tumor Hypoxia: Radionuclide-based Biomarker as Diagnostic Tools.
Saxena P; Gambhir S; Dixit M
Curr Top Med Chem; 2023; 23(12):1136-1154. PubMed ID: 37190811
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.
Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B
J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461
[TBL] [Abstract][Full Text] [Related]
8. ⁶⁸Ga-labelled peptides for diagnosis of gastroenteropancreatic NET.
Ambrosini V; Campana D; Tomassetti P; Fanti S
Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S52-60. PubMed ID: 22388622
[TBL] [Abstract][Full Text] [Related]
9. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
10. Can gallium-68 compounds partly replace (18)F-FDG in PET molecular imaging?
Pagou M; Zerizer I; Al-Nahhas A
Hell J Nucl Med; 2009; 12(2):102-5. PubMed ID: 19675859
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 68Ga-labeled DOTA-nitroimidazole derivatives and their feasibilities as hypoxia imaging PET tracers.
Hoigebazar L; Jeong JM; Hong MK; Kim YJ; Lee JY; Shetty D; Lee YS; Lee DS; Chung JK; Lee MC
Bioorg Med Chem; 2011 Apr; 19(7):2176-81. PubMed ID: 21419635
[TBL] [Abstract][Full Text] [Related]
12. Novel multifunctional
Kwon YD; Lee JY; La MT; Lee SJ; Lee SH; Park JH; Kim HK
Eur J Med Chem; 2020 Mar; 189():112099. PubMed ID: 32014792
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography to assess hypoxia and perfusion in lung cancer.
Verwer EE; Boellaard R; van der Veldt AA
World J Clin Oncol; 2014 Dec; 5(5):824-44. PubMed ID: 25493221
[TBL] [Abstract][Full Text] [Related]
14. Clinical indications for Gallium-68 positron emission tomography imaging.
Khan MU; Khan S; El-Refaie S; Win Z; Rubello D; Al-Nahhas A
Eur J Surg Oncol; 2009 Jun; 35(6):561-7. PubMed ID: 19201567
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography/computed tomography guided percutaneous biopsies of Ga-68 avid lesions using an automated robotic arm.
Kumar R; Mittal BR; Bhattacharya A; Vadi SK; Singh H; Bal A; Shukla J; Singh H; Sharma V; Sood A; Singh SK
Diagn Interv Imaging; 2020 Mar; 101(3):157-167. PubMed ID: 31722844
[TBL] [Abstract][Full Text] [Related]
16. Gallium-68: a new trend in PET radiopharmacy.
Prata MI
Curr Radiopharm; 2012 Apr; 5(2):142-9. PubMed ID: 22280116
[TBL] [Abstract][Full Text] [Related]
17. (68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives.
Breeman WA; de Blois E; Sze Chan H; Konijnenberg M; Kwekkeboom DJ; Krenning EP
Semin Nucl Med; 2011 Jul; 41(4):314-21. PubMed ID: 21624565
[TBL] [Abstract][Full Text] [Related]
18. Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer.
Giovacchini G; Giovannini E; Riondato M; Ciarmiello A
Curr Radiopharm; 2017; 10(1):6-15. PubMed ID: 28034291
[TBL] [Abstract][Full Text] [Related]
19. Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole ( 18F-FAZA).
Postema EJ; McEwan AJ; Riauka TA; Kumar P; Richmond DA; Abrams DN; Wiebe LI
Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1565-73. PubMed ID: 19430784
[TBL] [Abstract][Full Text] [Related]
20. Clinical Translation and First In-Human Use of [
Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
